{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T15:02:41Z","timestamp":1793977361068,"version":"4.8.0"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1092642"],"award-info":[{"award-number":["1092642"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1087355"],"award-info":[{"award-number":["1087355"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1156693"],"award-info":[{"award-number":["1156693"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology Letters"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.toxlet.2021.07.012","type":"journal-article","created":{"date-parts":[[2021,7,22]],"date-time":"2021-07-22T18:49:38Z","timestamp":1626979778000},"page":"133-142","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Sphingolipid imbalance and inflammatory effects induced by uremic toxins in heart and kidney cells are reversed by dihydroceramide desaturase 1 inhibition"],"prefix":"10.1016","volume":"350","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0383-812X","authenticated-orcid":false,"given":"Feby","family":"Savira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Magaye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6347-5391","authenticated-orcid":false,"given":"Carmen V.","family":"Scullino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard L.","family":"Flynn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart M.","family":"Pitson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dovile","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darren J.","family":"Creek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Hua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danny","family":"Liew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9173-3944","authenticated-orcid":false,"given":"Christopher","family":"Reid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Kaye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew R.","family":"Kompa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9580-2548","authenticated-orcid":false,"given":"Bing Hui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.toxlet.2021.07.012_bib0005","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1186\/1471-2369-14-244","article-title":"Triggering of suicidal erythrocyte death by uremic toxin indoxyl sulfate","volume":"14","author":"Ahmed","year":"2013","journal-title":"BMC Nephrol."},{"key":"10.1016\/j.toxlet.2021.07.012_bib0010","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1159\/000350141","article-title":"The uremic toxin acrolein promotes suicidal erythrocyte death","volume":"37","author":"Ahmed","year":"2013","journal-title":"Kidney Blood Press. Res."},{"key":"10.1016\/j.toxlet.2021.07.012_bib0015","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.bbadis.2016.11.005","article-title":"Nrf2 signaling pathway: pivotal roles in inflammation","volume":"1863","author":"Ahmed","year":"2017","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"10.1016\/j.toxlet.2021.07.012_bib0020","doi-asserted-by":"crossref","first-page":"H319","DOI":"10.1152\/ajpheart.00453.2011","article-title":"Short-term magnesium deficiency upregulates ceramide synthase in cardiovascular tissues and cells: cross-talk among cytokines, Mg2+, NF-\u03baB, and de novo ceramide","volume":"302","author":"Altura","year":"2012","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.toxlet.2021.07.012_bib0025","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jss.2012.03.003","article-title":"Inhibitory kappa-B kinase-\u03b2 inhibition prevents adaptive left ventricular hypertrophy","volume":"178","author":"Andersen","year":"2012","journal-title":"J. Surg. Res."},{"key":"10.1016\/j.toxlet.2021.07.012_bib0030","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1021\/acs.jmedchem.5b01439","article-title":"From sphingosine kinase to dihydroceramide desaturase: a structure-activity relationship (SAR) study of the enzyme inhibitory and anticancer activity of 4-((4-(4-chlorophenyl)thiazol-2-yl)amino)phenol (SKI-II)","volume":"59","author":"Aurelio","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.toxlet.2021.07.012_bib0035","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/978-1-4614-0650-1_3","article-title":"Heart sphingolipids in health and disease","volume":"721","author":"Baranowski","year":"2011","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.toxlet.2021.07.012_bib0040","doi-asserted-by":"crossref","first-page":"5218","DOI":"10.1210\/en.2010-0355","article-title":"Decreased expression of natriuretic peptides associated with lipid accumulation in cardiac ventricle of obese mice","volume":"151","author":"Bartels","year":"2010","journal-title":"Endocrinology"},{"key":"10.1016\/j.toxlet.2021.07.012_bib0045","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1159\/000327139","article-title":"Statins and lipid-lowering strategies in cardiorenal patients","volume":"171","author":"Bianchi","year":"2011","journal-title":"Contrib. Nephrol."},{"key":"10.1016\/j.toxlet.2021.07.012_bib0050","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/1471-2369-14-56","article-title":"Indoxyl sulfate, a uremic toxin, downregulates renal expression of Nrf2 through activation of NF-kappaB","volume":"14","author":"Bolati","year":"2013","journal-title":"BMC Nephrol."},{"key":"10.1016\/j.toxlet.2021.07.012_bib0055","doi-asserted-by":"crossref","first-page":"986","DOI":"10.3389\/fphys.2019.00986","article-title":"Sphingolipid synthesis inhibition by myriocin administration enhances lipid consumption and ameliorates lipid response to myocardial ischemia reperfusion injury","volume":"10","author":"Bonezzi","year":"2019","journal-title":"Front. Physiol."},{"key":"10.1016\/j.toxlet.2021.07.012_bib0060","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s11255-018-2047-y","article-title":"The effect of chronic kidney disease on lipid metabolism","volume":"51","author":"Dincer","year":"2019","journal-title":"Int. Urol. Nephrol."},{"key":"10.1016\/j.toxlet.2021.07.012_bib0065","article-title":"Arylazoles as sphingosine kinase interacting agents and their preparation","author":"Flynn","year":"2015","journal-title":"PCT. Int. Appl."},{"key":"10.1016\/j.toxlet.2021.07.012_bib0070","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.cyto.2014.12.024","article-title":"The varying faces of IL-6: from cardiac protection to cardiac failure","volume":"74","author":"Fontes","year":"2015","journal-title":"Cytokine"},{"key":"10.1016\/j.toxlet.2021.07.012_bib0075","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.abb.2014.11.009","article-title":"Downregulation of adipose triglyceride lipase promotes cardiomyocyte hypertrophy by triggering the accumulation of ceramides","volume":"565","author":"Gao","year":"2015","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.toxlet.2021.07.012_bib0080","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1097\/SHK.0000000000000468","article-title":"Lipopolysaccharide disrupts mitochondrial physiology in skeletal muscle via disparate effects on sphingolipid metabolism","volume":"44","author":"Hansen","year":"2015","journal-title":"Shock"},{"key":"10.1016\/j.toxlet.2021.07.012_bib0085","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1038\/ki.1991.120","article-title":"Elevated circulating levels of interleukin-6 in patients with chronic renal failure","volume":"39","author":"Herbelin","year":"1991","journal-title":"Kidney Int."},{"key":"10.1016\/j.toxlet.2021.07.012_bib0090","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.matbio.2018.01.006","article-title":"Sphingolipid signaling in renal fibrosis","volume":"68\u201369","author":"Huwiler","year":"2018","journal-title":"Matrix Biol."},{"key":"10.1016\/j.toxlet.2021.07.012_bib0095","doi-asserted-by":"crossref","first-page":"3057","DOI":"10.1038\/s41598-017-03130-z","article-title":"Indoxyl sulfate (IS)-mediated immune dysfunction provokes endothelial damage in patients with end-stage renal disease (ESRD)","volume":"7","author":"Kim","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.toxlet.2021.07.012_bib0100","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1681\/ASN.2012050503","article-title":"p-Cresyl sulfate promotes insulin resistance associated with CKD","volume":"24","author":"Koppe","year":"2013","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.toxlet.2021.07.012_bib0105","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.bbrc.2017.10.110","article-title":"Dihydroceramide is a key metabolite that regulates autophagy and promotes fibrosis in hepatic steatosis model","volume":"494","author":"Lee","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.toxlet.2021.07.012_bib0110","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1093\/eurheartj\/ehp574","article-title":"Does indoxyl sulfate, a uraemic toxin, have direct effects on cardiac fibroblasts and myocytes?","volume":"31","author":"Lekawanvijit","year":"2010","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.toxlet.2021.07.012_bib0115","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0041281","article-title":"Chronic kidney disease-induced cardiac fibrosis is ameliorated by reducing circulating levels of a non-dialysable uremic toxin, indoxyl sulfate","volume":"7","author":"Lekawanvijit","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.toxlet.2021.07.012_bib0120","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1097\/CM9.0000000000000601","article-title":"Role of dihydroceramides in the progression of acute-on-chronic liver failure in rats","volume":"133","author":"Li","year":"2020","journal-title":"Chin. Med. J. (Engl.)"},{"key":"10.1016\/j.toxlet.2021.07.012_bib0125","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1016\/j.ijcard.2012.12.065","article-title":"Subtotal nephrectomy accelerates pathological cardiac remodeling post-myocardial infarction: implications for cardiorenal syndrome","volume":"168","author":"Liu","year":"2013","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.toxlet.2021.07.012_bib0130","first-page":"2918","article-title":"Cardiovascular disease and its relationship with chronic kidney disease","volume":"18","author":"Liu","year":"2014","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.toxlet.2021.07.012_bib0135","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1007\/s00018-018-2984-8","article-title":"The role of dihydrosphingolipids in disease","volume":"76","author":"Magaye","year":"2019","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.toxlet.2021.07.012_bib0140","doi-asserted-by":"crossref","first-page":"485","DOI":"10.2217\/fca.11.24","article-title":"Kidney and heart interactions during cardiorenal syndrome: a molecular and clinical pathogenic framework","volume":"7","author":"Napoli","year":"2011","journal-title":"Future Cardiol."},{"key":"10.1016\/j.toxlet.2021.07.012_bib0145","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.cardiores.2005.10.001","article-title":"The role of natriuretic peptides in cardioprotection","volume":"69","author":"Nishikimi","year":"2006","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.toxlet.2021.07.012_bib0150","doi-asserted-by":"crossref","first-page":"641","DOI":"10.3109\/10715762.2014.898294","article-title":"The uremic toxin indoxyl sulfate acts as a pro- or antioxidant on LDL oxidation","volume":"48","author":"Praschberger","year":"2014","journal-title":"Free Radic. Res."},{"key":"10.1016\/j.toxlet.2021.07.012_bib0155","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jep.2015.05.010","article-title":"Integrated targeted sphingolipidomics and transcriptomics reveal abnormal sphingolipid metabolism as a novel mechanism of the hepatotoxicity and nephrotoxicity of triptolide","volume":"170","author":"Qu","year":"2015","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.toxlet.2021.07.012_bib0160","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.bbalip.2014.09.021","article-title":"Dihydroceramide desaturase 1, the gatekeeper of ceramide induced lipotoxicity","volume":"1851","author":"Rodriguez-Cuenca","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.toxlet.2021.07.012_bib0165","doi-asserted-by":"crossref","first-page":"3919","DOI":"10.1172\/JCI63888","article-title":"Ceramide synthase 5 mediates lipid-induced autophagy and hypertrophy in cardiomyocytes","volume":"122","author":"Russo","year":"2012","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.toxlet.2021.07.012_bib0170","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0187459","article-title":"Apoptosis signal-regulating kinase 1 inhibition attenuates cardiac hypertrophy and cardiorenal fibrosis induced by uremic toxins: implications for cardiorenal syndrome","volume":"12","author":"Savira","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.toxlet.2021.07.012_bib0175","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.toxlet.2019.03.002","article-title":"Molecular mechanisms of protein-bound uremic toxin-mediated cardiac, renal and vascular effects: underpinning intracellular targets for cardiorenal syndrome therapy","volume":"308","author":"Savira","year":"2019","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.toxlet.2021.07.012_bib0180","doi-asserted-by":"crossref","first-page":"123","DOI":"10.2174\/1874312901206010123","article-title":"Sphingolipid regulation of tissue fibrosis","volume":"6","author":"Shea","year":"2012","journal-title":"Open Rheumatol. J."},{"key":"10.1016\/j.toxlet.2021.07.012_bib0185","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1128\/MCB.00226-13","article-title":"Ablation of dihydroceramide desaturase 1, a therapeutic target for the treatment of metabolic diseases, simultaneously stimulates anabolic and catabolic signaling","volume":"33","author":"Siddique","year":"2013","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.toxlet.2021.07.012_bib0190","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1161\/01.RES.56.6.884","article-title":"Stimulation of hypertrophy of cultured neonatal rat heart cells through an alpha 1-adrenergic receptor and induction of beating through an alpha 1- and beta 1-adrenergic receptor interaction. Evidence for independent regulation of growth and beating","volume":"56","author":"Simpson","year":"1985","journal-title":"Circ. Res."},{"key":"10.1016\/j.toxlet.2021.07.012_bib0195","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s11255-017-1748-y","article-title":"From bench to the hemodialysis clinic: protein-bound uremic toxins modulate NF-\u03baB\/Nrf2 expression","volume":"50","author":"Stockler-Pinto","year":"2018","journal-title":"Int. Urol. Nephrol."},{"key":"10.1016\/j.toxlet.2021.07.012_bib0200","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1161\/CIRCHEARTFAILURE.114.001785","article-title":"Angiotensin receptor neprilysin inhibitor LCZ696 attenuates cardiac remodeling and dysfunction after myocardial infarction by reducing cardiac fibrosis and hypertrophy","volume":"8","author":"von Lueder","year":"2015","journal-title":"Circ. Heart Fail."},{"key":"10.1016\/j.toxlet.2021.07.012_bib0205","doi-asserted-by":"crossref","first-page":"126","DOI":"10.4049\/jimmunol.1403149","article-title":"Vitamin E \u03b3-tocotrienol inhibits cytokine-stimulated NF-\u03baB activation by induction of anti-inflammatory A20 via stress adaptive response due to modulation of sphingolipids","volume":"195","author":"Wang","year":"2015","journal-title":"J. Immunol."},{"key":"10.1016\/j.toxlet.2021.07.012_bib0210","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1038\/ki.2012.448","article-title":"p-Cresyl sulfate causes renal tubular cell damage by inducing oxidative stress by activation of NADPH oxidase","volume":"83","author":"Watanabe","year":"2013","journal-title":"Kidney Int."},{"key":"10.1016\/j.toxlet.2021.07.012_bib0215","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1002\/jcp.24296","article-title":"NF-\u03baB mediated miR-26a regulation in cardiac fibrosis","volume":"228","author":"Wei","year":"2013","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.toxlet.2021.07.012_bib0220","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.toxlet.2015.01.021","article-title":"Indoxyl sulfate induces oxidative stress and hypertrophy in cardiomyocytes by inhibiting the AMPK\/UCP2 signaling pathway","volume":"234","author":"Yang","year":"2015","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.toxlet.2021.07.012_bib0225","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1016\/j.lfs.2013.05.008","article-title":"Indoxyl sulfate promotes cardiac fibrosis with enhanced oxidative stress in hypertensive rats","volume":"92","author":"Yisireyili","year":"2013","journal-title":"Life Sci."},{"key":"10.1016\/j.toxlet.2021.07.012_bib0230","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1139\/y01-039","article-title":"Pathophysiological significance and clinical application of ANP and BNP in patients with heart failure","volume":"79","author":"Yoshimura","year":"2001","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.toxlet.2021.07.012_bib0235","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/ki.1997.304","article-title":"Altered ceramide and sphingosine expression during the induction phase of ischemic acute renal failure","volume":"52","author":"Zager","year":"1997","journal-title":"Kidney Int."},{"key":"10.1016\/j.toxlet.2021.07.012_bib0240","first-page":"7533","article-title":"Research on mechanism of PCS in damaging vascular endothelial cells and promoting formation of atherosclerosis via TLR4\/TREM-1","volume":"22","author":"Zhang","year":"2018","journal-title":"Eur. Rev. Med. Pharmacol. Sci."}],"container-title":["Toxicology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378427421001922?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378427421001922?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T16:53:53Z","timestamp":1777568033000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378427421001922"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":48,"alternative-id":["S0378427421001922"],"URL":"https:\/\/doi.org\/10.1016\/j.toxlet.2021.07.012","relation":{},"ISSN":["0378-4274"],"issn-type":[{"value":"0378-4274","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sphingolipid imbalance and inflammatory effects induced by uremic toxins in heart and kidney cells are reversed by dihydroceramide desaturase 1 inhibition","name":"articletitle","label":"Article Title"},{"value":"Toxicology Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.toxlet.2021.07.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}